Middletown, DE -- (SBWIRE) -- 09/10/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Mondelez International Inc (NASDAQ:MDLZ), Twenty-First Century Fox Inc (NASDAQ:FOXA), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), NetApp Inc. (NASDAQ:NTAP)
Mondelez International Inc (NASDAQ:MDLZ) opened the session at $30.91, remained amid the day range of $30.79 - $31.15, and closed the session at $31.11. The stock showed a positive performance of +0.55% in previous trading session. The stock gained a volume of 6.23 million shares and the average volume of the stock remained 8.65 million shares. Mondelez International, Inc., together with its subsidiaries, manufactures and markets snack food and beverage products worldwide. The company offers biscuits, including cookies, crackers, and salted snacks; confectionery products, such as chocolates, gums, and candies; powdered beverages and coffee; and cheese and grocery products.
Why Should Investors Buy MDLZ After The Recent Gain? Just Go Here and Find Out
Twenty-First Century Fox Inc(NASDAQ:FOXA) traded with volume of 6.17 million shares in the prior session and the average volume of the stock remained 11.56 million shares. The 52 week range of the stock remained $26.99 - $33.84. The stock showed a positive movement of +0.48% and closed its session at $32.13. The market capitalization of the stock remained 74.21 billion. Twenty-First Century Fox, Inc. operates as a diversified media and entertainment company worldwide. The company?s Cable Network Programming segment produces and licenses news, business news, sports, general entertainment, and movie programming for distribution through cable television systems, direct broadcast satellite operators.
Will FOXA Continue To Move Higher? Find Out Here
Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) exchanged 5.91 million shares and the average volume remained 2.55 million shares. The stock dropped -2.06% and closed the session at $21.85. The beta of the stock remained 1.27 and the EPS of the stock remained -1.42. The shares outstanding of the stock remained 185.11 million. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing additional molecularly targeted therapies to treat patients with blood cancers and solid tumors.
Has ARIA Found The Bottom And Ready To Gain Momentum? Find Out Here
NetApp Inc. (NASDAQ:NTAP) opened the session at $42.88, remained amid the day range of $42.37 - $42.98, and closed the session at $42.76. The stock showed a positive performance of +1.23% in previous trading session. The stock gained a volume of 5.92 million shares and the average volume of the stock remained 5.40 million shares. NetApp, Inc. engages in design, manufacture, and marketing of networked storage solutions. The company supplies enterprise storage and data management software and hardware products and services. It offers FAS Storage Platform based on Data ONTAP, an operating system (OS) that supports storage area network (SAN) and network-attached storage (NAS) environments; storage efficiency technologies.
For How Long NTAP’s Gloss will Attract Investors? Find out via this report
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)